Quality of life assessment in the randomized PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients with Atrial Fibrillation) trial of patients at risk for stroke with nonvalvular atrial fibrillation

Journal of the American College of Cardiology

Volumn 61, Issue 17, 2013, Pages 1790-1798

  Alli, Oluseun ^a   Doshi, Shepal ^b   Kar, Saibal ^c   Reddy, Vivek ^d   Sievert, Horst ^e   Mullin, Chris ^f   Swarup, Vijay ^g   Whisenant, Brian ^h   Holmes, David ⁱ  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b Pacific Heart Institute   (United States)

^c CEDARS SINAI MEDICAL CENTER   (United States)

^d MOUNT SINAI MEDICAL CENTER   (United States)

^e Sankt Katharinen Krankenhaus GmbH   (Germany)

^f Integra Group   (United States)

^g Arizona Heart Hospital   (United States)

^h INTERMOUNTAIN MEDICAL CENTER   (United States)

ⁱ MAYO CLINIC   (United States)

Author keywords

atrial fibrillation; health related quality of life; left atrial appendage occlusion; stroke prevention; warfarin

Indexed keywords

WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; CARDIOVASCULAR EQUIPMENT; CEREBROVASCULAR ACCIDENT; CHADS2 SCORE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART ATRIUM APPENDAGE; HEART ATRIUM FIBRILLATION; HUMAN; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; LEFT ATRIAL APPENDAGE CLOSURE DEVICE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); PERCUTANEOUS LEFT ATRIAL APPENDAGE CLOSURE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SHORT FORM 12;

EID: 84876580352     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.01.061     Document Type: Article

References (30)

1. M.D. Ezekowitz, S.L. Bridgers, K.E. James Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation N Engl J Med 327 1992 1406 1412
2. R.G. Hart, L.A. Pearce, M.I. Aguilar Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation Ann Intern Med 146 2007 857 867
3. P. Petersen, G. Boysen, J. Godtfredsen, E.D. Andersen, B. Andersen Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation The Copenhagen AFASAK study Lancet 1 1989 175 179
4. D.R. Holmes, V.Y. Reddy, Z.G. Turi Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial Lancet 374 2009 534 542
5. G. Thrall, D. Lane, D. Carroll, G.Y. Lip Quality of life in patients with atrial fibrillation: a systematic review Am J Med 119 2006 448.e1 448.e19
6. A.K. Das, P.D. Willcoxson, O.J. Corrado, R.M. West The impact of long-term warfarin on the quality of life of elderly people with atrial fibrillation Age Ageing 36 2007 95 97
7. T.R. Lancaster, D.E. Singer, M.A. Sheehan Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators The impact of long-term warfarin therapy on quality of life. Evidence from a randomized trial Arch Intern Med 151 1991 1944 1949
8. S. Dierkes, M.G. Hennersdorf, E.G. Vester, C. Perings [Long-term follow-up of right atrial multilinear high-frequency ablation in the treatment of recurrent paroxysmal atrial fibrillation] Deutsche Medizinische Wochenschrift 128 2003 130 134
9. A. Erdogan, J. Carlsson, T. Neumann Quality-of-life in patients with paroxysmal atrial fibrillation after catheter ablation: results of long-term follow-up PACE 26 2003 678 684
10. A. Goldberg, M. Menen, S. Mickelsen Atrial fibrillation ablation leads to long-term improvement of quality of life and reduced utilization of healthcare resources J Intervent Card Electrophysiol 8 2003 59 64
11. H. Tada, S. Naito, K. Kurosaki Segmental pulmonary vein isolation for paroxysmal atrial fibrillation improves quality of life and clinical outcomes Circ J 67 2003 861 865
12. H. Purerfellner, M. Martinek, J. Aichinger, H.J. Nesser, K. Kempen, J.P. Janssen Quality of life restored to normal in patients with atrial fibrillation after pulmonary vein ostial isolation Am Heart J 148 2004 318 325
13. G.N. Kay, R.S. Bubien, A.E. Epstein, V.J. Plumb Effect of catheter ablation of the atrioventricular junction on quality of life and exercise tolerance in paroxysmal atrial fibrillation Am J Cardiol 62 1988 741 744
14. A. Natale, L. Zimerman, G. Tomassoni Impact on ventricular function and quality of life of transcatheter ablation of the atrioventricular junction in chronic atrial fibrillation with a normal ventricular response Am J Cardiol 78 1996 1431 1433
15. A.P. Fitzpatrick, H.D. Kourouyan, A. Siu Quality of life and outcomes after radiofrequency His-bundle catheter ablation and permanent pacemaker implantation: impact of treatment in paroxysmal and established atrial fibrillation Am Heart J 131 1996 499 507
16. H.J. Duff, S.R. Raj, D.V. Exner Randomized controlled trial of fixed rate versus rate responsive pacing after radiofrequency atrioventricular junction ablation: quality of life, ventricular refractoriness, and paced QT dispersion J Cardiovasc Electrophysiol 14 2003 1163 1170
17. J. Carlsson, S. Miketic, J. Windeler Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study J Am Coll Cardiol 41 2003 1690 1696
18. G.C. Gronefeld, J. Lilienthal, K.H. Kuck, S.H. Hohnloser Pharmacological intervention in atrial fibrillation study I. Impact of rate versus rhythm control on quality of life in patients with persistent atrial fibrillation. Results from a prospective randomized study Eur Heart J 24 2003 1430 1436
19. V.E. Hagens, A.V. Ranchor, E. Van Sonderen Effect of rate or rhythm control on quality of life in persistent atrial fibrillation Results from the Rate Control Versus Electrical Cardioversion (RACE) study J Am Coll Cardiol 43 2004 241 247
20. L.S. Jenkins, M. Brodsky, E. Schron Quality of life in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study Am Heart J 149 2005 112 120
21. B.F. Gage, A.D. Waterman, W. Shannon, M. Boechler, M.W. Rich, M.J. Radford Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation JAMA 285 2001 2864 2870
22. R.B. Fountain, D.R. Holmes, K. Chandrasekaran The PROTECT AF (WATCHMAN Left Atrial Appendage System for Embolic Protection in Patients With Atrial Fibrillation) trial Am Heart J 151 2006 956 961
23. P.B. Sick, G. Schuler, K.E. Hauptmann Initial worldwide experience with the WATCHMAN left atrial appendage system for stroke prevention in atrial fibrillation J Am Coll Cardiol 49 2007 1490 1495
24. C.A. McHorney, J.E. Ware Jr., A.E. Raczek The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs Med Care 31 1993 247 263
25. A.K. Wagner, B. Gandek, N.K. Aaronson Cross-cultural comparisons of the content of SF-36 translations across 10 countries: results from the IQOLA Project International Quality of Life Assessment J Clin Epidemiol 51 1998 925 932
26. J. Ware Jr., M. Kosinski, S.D. Keller A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity Med Care 34 1996 220 233
27. K.W. Wyrwich, J.A. Spertus, K. Kroenke Clinically important differences in health status for patients with heart disease: an expert consensus panel report Am Heart J 147 2004 615 622
28. J. Ware, M. Kosinki, J.B. Bjorner, D.M. Turner-Bowker, B. Gandek, M.E. Maruish Determining Important Differences in Scores User's Manual for the SF-36v2 Health Survey 2007 Quality Metric Lincoln, RI
29. A.K. Das, A. Ahmed, O.J. Corrado, R.M. West Quality of life of elderly people on warfarin for atrial fibrillation Age Ageing 38 2009 751 754
30. A. Wokhlu, K.H. Monahan, D.O. Hodge Long-term quality of life after ablation of atrial fibrillation the impact of recurrence, symptom relief, and placebo effect J Am Coll Cardiol 55 2010 2308 2316